8-K
filed July 15, 2024, 7:59 PM ET
ticker LPAA
CIK 0002015502
other material
confidence high
sentiment neutral
materiality 0.50
Launch One Acquisition Corp. closes $230M IPO, trust funded
Launch One Acquisition Corp.
- Closed IPO of 23,000,000 units at $10.00/unit, gross proceeds $230M; includes full over-allotment exercise.
- Issued 6M private placement warrants ($1 each) to sponsor (4M) and Cantor (2M), raising $6M; exercisable at $11.50.
- Placed $230M of total proceeds into trust; funds released only upon business combination or liquidation within 24 months.
- Amended sponsor promissory note: loan limit increased from $300K to $340K, no interest, repayable at IPO closing.
- SPAC focus is healthcare/life sciences globally; led by CEO Chris Ehrlich, Chairman Ryan Gilbert, CFO Jurgen van de Vyver.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001213900-24-061349
- form_type
- 8-K
- ticker
- LPAA
- cik
- 0002015502
- company_name
- Launch One Acquisition Corp.
- filed_at
- 2024-07-15T23:59:59+00:00
- discovered_at
- 2026-05-14T18:03:15.361065+00:00
- generated_at
- 2026-05-31T20:52:11.246739+00:00
- sec_items
- ["1.01", "2.03", "3.02", "5.03", "8.01", "9.01"]
- event_type
- other_material
- sentiment
- neutral
- materiality_score
- 0.5
- calibrated_materiality_score
- 0.5
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001213900-24-061349
- json_url
- https://secwatch.observer/filing/0001213900-24-061349.json
- markdown_url
- https://secwatch.observer/filing/0001213900-24-061349.md
- text_url
- https://secwatch.observer/filing/0001213900-24-061349.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/2015502/000121390024061349/0001213900-24-061349-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/2015502/000121390024061349/ea0209363-8k_launch.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
JAGX
Jaguar Health issues 64,668 common shares for Series Q Preferred; annual meeting adjourned to June 8
Jaguar Health, Inc.
June 2, 2026, 4:10 PM ET
other_material
Items 1.01, 3.02, 8.01, 9.01
same SEC item: 1.01, 3.02, 8.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
XWIN
XMax raises $3.6M via private placement of 486,500 shares at $7.347/share
XMax Inc.
June 2, 2026, 4:30 PM ET
other_material
Items 1.01, 3.02, 9.01
same SEC item: 1.01, 3.02, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
OTAI
Starlink AI Acquisition closes partial over-allotment, adds $5M to trust
Starlink AI Acquisition Corp
June 2, 2026, 4:05 PM ET
other_material
Items 3.02, 8.01, 9.01
same SEC item: 3.02, 8.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
GIPR
Generation Income Properties prices $5.0M public offering of 23.8M shares and warrants at $0.21/unit
GENERATION INCOME PROPERTIES, INC.
June 1, 2026, 5:27 PM ET
other_material
Items 1.01, 8.01, 9.01
same SEC item: 1.01, 8.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
NRXP
NRx Pharmaceuticals proposes public offering of common stock; terms not set
NRX Pharmaceuticals, Inc.
June 2, 2026, 5:30 PM ET
other_material
Items 8.01, 9.01
same SEC item: 8.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
Partners Group Lending Fund, LLC
Partners Group Lending Fund reports April 30 NAV of $1.5013/unit; portfolio $501.1M
Partners Group Lending Fund, LLC
June 2, 2026, 5:12 PM ET
other_material
Items 3.02, 8.01
same SEC item: 3.02, 8.01
same event type: other_material
similar materiality
Filing page
SEC filing
AVA
Avista signs non-binding MOU for 125 MW load, expandable to 500 MW by 2032
AVISTA CORP
June 2, 2026, 5:02 PM ET
other_material
Items 8.01, 9.01
same SEC item: 8.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
ARVN
Arvinas to out-license ARV-806 after completing Phase 1 dose escalation
ARVINAS, INC.
June 2, 2026, 4:39 PM ET
other_material
Items 7.01, 8.01, 9.01
same SEC item: 8.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.